Voltaic Strategic Resources

Showing 1937 articles
Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Business

HubSpot's Strategic Shift: Upmarket Gains and AI Agents Fuel Growth Amid SMB Softness

Wall Street analysts are reaffirming confidence in HubSpot's long-term strategy, pointing to its successful expansion into larger enterprise clients and the integration of AI agents across its platform. While concerns linger over softening demand from small and mid-sized businesses, the company's focus on multi-hub adoption and upmarket contracts is seen as reshaping its core growth engine.